Aurobindo Pharma is ranked among the top 10 generic pharma companies in the world and is an integrated large global pharmaceutical company with a presence in over 155 countries, with planned expansion in new territories such as Poland, Italy, Spain, Czech Republic, Portugal and France. Aurobindo’s marketing partners include Astra Zeneca and Pfizer. The company’s area of activity includes six major therapeutic/product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. Aurobindo Pharma plans to expand its product portfolio with high-value products in oncology, hormones, biosimilars and novel drug delivery solutions like depot injections, inhalers, patches and films.